Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Chemopreventive potential of an ethyl acetate fraction from Curcuma longa is associated with upregulation of p57(kip2) and Rad9 in the PC-3M prostate cancer cell line.

Rao KV, Samikkannu T, Dakshayani KB, Zhang X, Sathaye SS, Indap MA, Nair MP.

Asian Pac J Cancer Prev. 2012;13(3):1031-8.

2.

Combinatorial cytotoxic effects of Curcuma longa and Zingiber officinale on the PC-3M prostate cancer cell line.

Kurapati KR, Samikkannu T, Kadiyala DB, Zainulabedin SM, Gandhi N, Sathaye SS, Indap MA, Boukli N, Rodriguez JW, Nair MP.

J Basic Clin Physiol Pharmacol. 2012;23(4):139-46. doi: 10.1515/jbcpp-2012-0021.

3.

Antibacterial activity of Curcuma longa L. against methicillin-resistant Staphylococcus aureus.

Kim KJ, Yu HH, Cha JD, Seo SJ, Choi NY, You YO.

Phytother Res. 2005 Jul;19(7):599-604.

PMID:
16161063
4.

MicroRNA-21 inhibits p57Kip2 expression in prostate cancer.

Mishra S, Lin CL, Huang TH, Bouamar H, Sun LZ.

Mol Cancer. 2014 Sep 12;13:212. doi: 10.1186/1476-4598-13-212.

5.

Down-regulation of p57Kip2 induces prostate cancer in the mouse.

Jin RJ, Lho Y, Wang Y, Ao M, Revelo MP, Hayward SW, Wills ML, Logan SK, Zhang P, Matusik RJ.

Cancer Res. 2008 May 15;68(10):3601-8. doi: 10.1158/0008-5472.CAN-08-0073.

6.

Piper betel leaf extract: anticancer benefits and bio-guided fractionation to identify active principles for prostate cancer management.

Paranjpe R, Gundala SR, Lakshminarayana N, Sagwal A, Asif G, Pandey A, Aneja R.

Carcinogenesis. 2013 Jul;34(7):1558-66. doi: 10.1093/carcin/bgt066. Epub 2013 Feb 21.

PMID:
23430955
7.

Downregulation of p57kip² promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells.

Chow SE, Wang JS, Lin MR, Lee CL.

J Cell Biochem. 2011 Nov;112(11):3459-68. doi: 10.1002/jcb.23277.

PMID:
21769918
8.

Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells.

Albrecht M, Jiang W, Kumi-Diaka J, Lansky EP, Gommersall LM, Patel A, Mansel RE, Neeman I, Geldof AA, Campbell MJ.

J Med Food. 2004 Fall;7(3):274-83.

PMID:
15383219
9.
10.

The effect of turmeric extracts on inflammatory mediator production.

Lantz RC, Chen GJ, Solyom AM, Jolad SD, Timmermann BN.

Phytomedicine. 2005 Jun;12(6-7):445-52.

PMID:
16008121
11.

In vitro anti-prostate cancer and ex vivo antiangiogenic activity of Vernonia guineensis Benth. (Asteraceae) tuber extracts.

Toyang NJ, Wabo HK, Ateh EN, Davis H, Tane P, Kimbu SF, Sondengam LB, Bryant J.

J Ethnopharmacol. 2012 Jun 14;141(3):866-71. doi: 10.1016/j.jep.2012.03.021. Epub 2012 Mar 23.

PMID:
22465590
12.

Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer.

Ranga RS, Girija R, Nur-e-Alam M, Sathishkumar S, Akbarsha MA, Thirugnanam S, Rohr J, Ahmed MM, Chendil D.

Cancer Chemother Pharmacol. 2004 Jul;54(1):7-15. Epub 2004 Mar 24.

PMID:
15042313
13.

Curcuma longa and Curcuma mangga leaves exhibit functional food property.

Liu Y, Nair MG.

Food Chem. 2012 Nov 15;135(2):634-40. doi: 10.1016/j.foodchem.2012.04.129. Epub 2012 May 8.

PMID:
22868139
14.

Bioactive chemical constituents of Curcuma longa L. rhizomes extract inhibit the growth of human hepatoma cell line (HepG2).

Abdel-Lateef E, Mahmoud F, Hammam O, El-Ahwany E, El-Wakil E, Kandil S, Abu Taleb H, El-Sayed M, Hassenein H.

Acta Pharm. 2016 Sep 1;66(3):387-98. doi: 10.1515/acph-2016-0028.

PMID:
27383887
15.

Cytotoxic constituents from the rhizomes of Curcuma zedoaria.

Ahmed Hamdi OA, Syed Abdul Rahman SN, Awang K, Abdul Wahab N, Looi CY, Thomas NF, Abd Malek SN.

ScientificWorldJournal. 2014;2014:321943. doi: 10.1155/2014/321943. Epub 2014 Jul 13.

16.

Antiproliferative activities of lesser galangal (Alpinia officinarum Hance Jam1), turmeric (Curcuma longa L.), and ginger (Zingiber officinale Rosc.) against acute monocytic leukemia.

Omoregie SN, Omoruyi FO, Wright VF, Jones L, Zimba PV.

J Med Food. 2013 Jul;16(7):647-55. doi: 10.1089/jmf.2012.0254. Epub 2013 Jul 2.

PMID:
23819642
17.

P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.

Li Y, Wang D, Zhang H, Wang C, Dai W, Cheng Z, Wang G, Li F.

Anat Rec (Hoboken). 2013 Oct;296(10):1561-7. doi: 10.1002/ar.22754. Epub 2013 Jul 19.

18.

An Ethanol Extract of Hawaiian Turmeric: Extensive In Vitro Anticancer Activity Against Human Colon Cancer Cells.

Dimas K, Tsimplouli C, Houchen C, Pantazis P, Sakellaridis N, Tsangaris GT, Anastasiadou E, Ramanujam RP.

Altern Ther Health Med. 2015;21 Suppl 2:46-54.

PMID:
26308760
19.

CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6.

Chen B, Zhao R, Su CH, Linan M, Tseng C, Phan L, Fang L, Yang HY, Yang H, Wang W, Xu X, Jiang N, Cai S, Jin F, Yeung SC, Lee MH.

Cell Cycle. 2012 Dec 15;11(24):4633-41. doi: 10.4161/cc.22887. Epub 2012 Nov 27.

20.

Inhibition of lung cancer cells A549 and H460 by curcuminoid extracts and nanoemulsions prepared from Curcuma longa Linnaeus.

Chang HB, Chen BH.

Int J Nanomedicine. 2015 Aug 5;10:5059-80. doi: 10.2147/IJN.S87225. eCollection 2015.

Supplemental Content

Support Center